oca
Generic: obeticholic acid·Code: OCA
oca: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Phase 3 |
Clinical Trials (1)
A Phase 2, Double-Blind, Randomized, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Obeticholic Acid Administered in Combination With Bezafibrate in Subjects With Primary Biliary Cholangitis Who Had an Inadequate Response or Who Were Unable to Tolerate Ursodeoxycholic Acid
Frequently asked questions
Who is developing oca?
oca is being developed by INTERCEPT PHARMACEUTICALS, INC..
How many clinical trials involve oca?
BioSniper tracks 1 clinical trial involving oca.
Get deeper analysis on oca
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis